FINANCIERE DE TUBIZE (TUB.BR) Stock Fundamental Analysis

EBR:TUB • BE0003823409

222.5 EUR
-1 (-0.45%)
Last: Feb 27, 2026, 11:56 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Taking everything into account, TUB scores 3 out of 10 in our fundamental rating. TUB was compared to 52 industry peers in the Pharmaceuticals industry. No worries on liquidiy or solvency for TUB as it has an excellent financial health rating, but there are worries on the profitability. TUB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year TUB was profitable.
  • In the past year TUB has reported a negative cash flow from operations.
  • TUB had positive earnings in each of the past 5 years.
  • TUB had a negative operating cash flow in each of the past 5 years.
TUB.BR Yearly Net Income VS EBIT VS OCF VS FCFTUB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

1.2 Ratios

  • With a Return On Assets value of 4.79%, TUB perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
  • TUB has a Return On Equity of 4.79%. This is in the lower half of the industry: TUB underperforms 61.54% of its industry peers.
Industry RankSector Rank
ROA 4.79%
ROE 4.79%
ROIC N/A
ROA(3y)4.63%
ROA(5y)5.57%
ROE(3y)4.88%
ROE(5y)5.78%
ROIC(3y)N/A
ROIC(5y)N/A
TUB.BR Yearly ROA, ROE, ROICTUB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

  • TUB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TUB.BR Yearly Profit, Operating, Gross MarginsTUB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, TUB has about the same amount of shares outstanding.
  • Compared to 5 years ago, TUB has more shares outstanding
  • The debt/assets ratio for TUB has been reduced compared to a year ago.
TUB.BR Yearly Shares OutstandingTUB.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
TUB.BR Yearly Total Debt VS Total AssetsTUB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 16264.96 indicates that TUB is not in any danger for bankruptcy at the moment.
  • TUB's Altman-Z score of 16264.96 is amongst the best of the industry. TUB outperforms 100.00% of its industry peers.
  • TUB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 16264.96
ROIC/WACCN/A
WACCN/A
TUB.BR Yearly LT Debt VS Equity VS FCFTUB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • TUB has a Current Ratio of 10.33. This indicates that TUB is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 10.33, TUB belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • TUB has a Quick Ratio of 10.33. This indicates that TUB is financially healthy and has no problem in meeting its short term obligations.
  • TUB has a Quick ratio of 10.33. This is amongst the best in the industry. TUB outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 10.33
Quick Ratio 10.33
TUB.BR Yearly Current Assets VS Current LiabilitesTUB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • TUB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.02%.
  • Measured over the past years, TUB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -20.68% on average per year.
EPS 1Y (TTM)3.02%
EPS 3Y2.13%
EPS 5Y-20.68%
EPS Q2Q%2.84%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TUB.BR Yearly Revenue VS EstimatesTUB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 50M 100M 150M 200M 250M

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 106.97, which means the current valuation is very expensive for TUB.
  • 69.23% of the companies in the same industry are cheaper than TUB, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.11. TUB is valued rather expensively when compared to this.
Industry RankSector Rank
PE 106.97
Fwd PE N/A
TUB.BR Price Earnings VS Forward Price EarningsTUB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TUB.BR Per share dataTUB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.31%, TUB is not a good candidate for dividend investing.
  • TUB's Dividend Yield is slightly below the industry average, which is at 1.89.
  • With a Dividend Yield of 0.31, TUB pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.31%

5.2 History

  • The dividend of TUB is nicely growing with an annual growth rate of 7.33%!
Dividend Growth(5Y)7.33%
Div Incr Years0
Div Non Decr Years0
TUB.BR Yearly Dividends per shareTUB.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • TUB pays out 0.05% of its income as dividend. This is a sustainable payout ratio.
DP0.05%
EPS Next 2YN/A
EPS Next 3YN/A
TUB.BR Yearly Income VS Free CF VS DividendTUB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M
TUB.BR Dividend Payout.TUB.BR Dividend Payout, showing the Payout Ratio.TUB.BR Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

FINANCIERE DE TUBIZE

EBR:TUB (2/27/2026, 11:56:49 AM)

222.5

-1 (-0.45%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)N/A
Earnings (Next)03-21
Inst Owners5.22%
Inst Owner ChangeN/A
Ins Owners33.27%
Ins Owner ChangeN/A
Market Cap9.90B
Revenue(TTM)N/A
Net Income(TTM)92.74M
Analysts76.67
Price Target235.11 (5.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.31%
Yearly Dividend0.97
Dividend Growth(5Y)7.33%
DP0.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 106.97
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.12
P/tB 5.12
EV/EBITDA N/A
EPS(TTM)2.08
EY0.93%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS43.5
TBVpS43.5
PEG (NY)N/A
PEG (5Y)N/A
Graham Number45.12
Profitability
Industry RankSector Rank
ROA 4.79%
ROE 4.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)4.63%
ROA(5y)5.57%
ROE(3y)4.88%
ROE(5y)5.78%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.33
Quick Ratio 10.33
Altman-Z 16264.96
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.02%
EPS 3Y2.13%
EPS 5Y-20.68%
EPS Q2Q%2.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-0.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.98%
OCF growth 3YN/A
OCF growth 5YN/A

FINANCIERE DE TUBIZE / TUB.BR FAQ

What is the fundamental rating for TUB stock?

ChartMill assigns a fundamental rating of 3 / 10 to TUB.BR.


What is the valuation status of FINANCIERE DE TUBIZE (TUB.BR) stock?

ChartMill assigns a valuation rating of 0 / 10 to FINANCIERE DE TUBIZE (TUB.BR). This can be considered as Overvalued.


How profitable is FINANCIERE DE TUBIZE (TUB.BR) stock?

FINANCIERE DE TUBIZE (TUB.BR) has a profitability rating of 1 / 10.


What are the PE and PB ratios of FINANCIERE DE TUBIZE (TUB.BR) stock?

The Price/Earnings (PE) ratio for FINANCIERE DE TUBIZE (TUB.BR) is 106.97 and the Price/Book (PB) ratio is 5.12.